XNK Therapeutics strengthens its scientific network with two more advisors
December 20[th], 2021
XNK Therapeutics AB (“XNK”) today announced the appointment of Dr. Gunilla Enblad, Professor of oncology at Uppsala University, and Dr. Rizwan Romee, Associate Professor of Medicine at Harvard Medical School, as scientific advisors. Together with the other advisors, they will play a key role in the future development of XNK’s proprietary technology platform of natural killer (NK) cell therapies within plasma cell disorders and hematological malignancies.Dr. Rizwan Romee is an Associate Professor of Medicine at Harvard Medical School and director of the